PLVAP, Human, mAb 174/2, FITC,Hycult Biotech,HM2214F

The monoclonal antibody 174/2 reacts with human plasmalemma vesicle associated protein (PLVAP), also known as PV1, PAL-E and FELS. PLVAP is a 60 kDa type II transmembrane glycoprotein which tends to form homodimers. PLVAP is widely expressed in the vasculature of normal tissues. The vascular staining pattern of PLVAP is quite unique among the endothelial cell antigens, since expression of other antigens (like ICAM-1, P-selectin, E-selectin or VCAM-1) is not limited to vascular endothelial cells. PLVAP expression in the vascular endothelial cells of the CNS is lost in association with formation of an intact blood-brain barrier. However, in the endothelium of human brain tumors expression of PLVAP is specifically up-regulated, making it a suitable antiangiogenic target for brain tumor therapy and cerebral edema. Furthermore, PLVAP is expressed in the vasculature of most other human tumors and as such useful as marker for tumor angiogenesis.

Host

Human

Platform ID

BAB260765561

Hycult Biotech

Headquarters

Frontstraat 2a 5405 PB Uden, The Netherlands

Contact

Tel: +31 (0)413 251335
Fax: +31(0)413 248353

Product Specifications

Specifications

NamePLVAP, Human, mAb 174/2, FITC
Cat. No.HM2214F
HostHuman
IsotypeMouse IgG1
Formulation0.2 ml (100 µg/ml) 0.2 µm filtered antibody solution in PBS, containing 1% bovine serum albumin and 0.02% sodium azide.
StorageProduct should be stored at 4 °C. Under recommended storage conditions, product is stable for one year.
Regulatory StatusResearch Use Only

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.